Retraction of “Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis”

Detalles Bibliográficos
Autores principales: Wu, Yanqiao, Sreeharsha, Nagaraja, Sharma, Sanjay, Mishra, Anurag, Singh, Avinash Kumar, Gubbiyappa, Shiva Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656203/
https://www.ncbi.nlm.nih.gov/pubmed/34901676
http://dx.doi.org/10.1021/acsomega.1c06159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656203/
https://www.ncbi.nlm.nih.gov/pubmed/34901676
http://dx.doi.org/10.1021/acsomega.1c06159

Ejemplares similares